The usefulness of home blood pressure monitoring in the managed care setting

Blood Pressure Monitoring

Volumn 3, Issue SUPPL. 1, 1998, Pages

  Wilson, Marcus ^a,b,c   Cziraky, Mark J ^a,b,c   Kalmanowicz, Jeffrey ^c  

^a HEALTHCORE INC   (United States)

^b UNIVERSITY OF THE SCIENCES   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Disease management; Home blood pressure monitoring; Hypertension; Managed care

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; DRUG COST; HEALTH ECONOMICS; HOME MONITORING; HUMAN; HYPERTENSION; MANAGED CARE ORGANIZATION; MARKETING; PATIENT COMPLIANCE; PRIORITY JOURNAL; WHITE COAT HYPERTENSION;

EID: 0032423930     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. FDC Reports, Inc. Weekly Pharmacy Reports. Chevy Chase, Maryland: FDC Reports, Inc. 1998; 47:1.
2. National Committee for Quality Assurance. Health Plan Employer Data and Information Set version 3.0 (HEDIS 3.0) Guidelines. Washington DC: National Committee for Quality Assurance; 1997.
3. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157:2413-2446.
4. Hodgson TA. American Heart Association (webpage) Cardiovasular Diseases. Statistics. 1998; http://www.amhrt.org/Scientific/Hsstats98/10econom.html (accessed 16 July 1998).
5. Pierin A, Gomes MAM, Segre CA, Mion D. Office versus home blood pressure monitoring and left ventricular mass index [abstract]. Am J Hypertens 1998; 11:66A.
6. Wilson MD, Johnson KA. Hypertension management in managed care: the role of home blood pressure monitoring. Blood Press Monit 1997; 2:201-206.
7. Strasser T. Self measurement of blood pressure: a statement by the World Hypertension League. J Hypertens 1988; 6:257-261.
8. Pickering T, Kaplan NM, Krakoff L, Prisant LM, Sheps S, Weber M, et al. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1995; 9:1-11.
9. Pickering TG, James GD. Some implications of the differences between home, clinic and ambulatory blood pressure in normotensive and hypertensive patients. J Hypertens 1989; 7:S65-S72.
10. Mengden T, Weisser B, Vetter W. Ambulatory 24-hour blood pressure versus self-measured blood pressure in pharmacologic trials. J Cardiovasc Pharmacol 1994; 24 (suppl 2):S20-S25.
11. Wilson M, Patwell J, Shoheiber O, Brixner D, Kalmanowicz J, Eicher J. The clinical and economic implication of drug utilization patterns in the treatment of hypertension with ACE inhibitors and calcium channel blockers in the managed care setting. J Managed Care Pharm 1998; 4:194-202.
12. Soghikian K, Casper SM, Fireman MA, Hunkeler EM, Hurley LB, Tekawa IS, et al. Home blood pressure monitoring: effect on use of medical services and medical care costs. Managed Care 1992; 30:855-865.
13. Wilson MD, Cziraky MJ. Taking charge of your own health: a practical guide to home blood pressure measurement. Dubuque, IA: Kendall/Hunt; 1995.
14. Diaz ME, Alves JM, Entenza C. Physicians' opinions and behaviour concerning the home measurement of blood pressure [abstract]. Am J Hypertens 1998; 11:52A.
15. Mejia A, Julius S. Practical utility of blood pressure readings obtained by self-determination. J Hypertens 1989; 7 (suppl 3):S53-S57.
16. Zachariah PK, Sheps SG, Smith RL. Clinical use of home and ambulatory blood pressure monitoring. Mayo Clin Proc 1989; 64:1436-1446.
17. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R, et al. White coat hypertension and white coat effect. Am J Hypertens 1995; 8:790-798.
18. Carney S. 24-Hour blood pressure monitoring: what are the benefits. Australian Prescriber 1997; 20 (http://www.australiaprescriber.com/magines/vol20no1/pressure.htm).
19. Becker RC, Corrao JM. Circadian variations in cardiovascular disease. Cleve Clin J Med 1989; 56:676-680.
20. Kawano Y, Tochikubo O, Minamisawa K, Miyajima E, Ishii M. Circadian variation of haemodynamics in patients with essential hypertension: comparison between early morning and evening. J Hypertens 1994; 12:1405-1412.
21. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79:733-743.
22. Smolensky MH, D'Alonzo GE. Medical chronobiology: concepts and applications. Am Rev Respir Dis 1993; 147:S2-S19.
23. White WB. Relevance of the trough-to-peak ratio to the 24-hour blood pressure load. Am J Hypertens 1996; 9:915-965.
24. Sclar DA, Chin A, Skaer TL, Okamoto MP, Nakahiro RK, Gill MK. Effect of health education in promoting refill compliance among patients with hypertension. Clin Therapeutics 1991; 13:489-495.
25. Swain MA, Steckel SB. Influencing adherence among hypertensives. Res Nurs Health 1981; 4:213-222.
26. Nessman DG, Carnahan JE, Nugent CA. Increasing compliance: patient oriented hypertension groups. Arch Intern Med 1980; 140:1427-1430.
27. Levine DM. Health education for hypertensive patients. JAMA 1979; 241:1700-1703.
28. Meyer D, Leventhal H, Guttman M. Common sense models of illness: the example of hypertension. Health Psychol 1985; 4:115-135.
29. Moriskey DE. Five year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1983; 73:153-162.